Neuro-oncology clinicians' perspectives on factors affecting brain cancer patients' access to medical assistance in dying: A qualitative study.

Autor: Variath C; Lawrence S Bloomberg School of Nursing, Joint Centre for Bioethics, University of Toronto, Toronto, Canada., Climans SA; Departments of Neurology and Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada., Edelstein K; Department of Psychiatry, University of Toronto, Toronto, Canada.; Department of Supportive Care, Princess Margaret Cancer Centre, Toronto, Canada., Bell JAH; Department of Psychiatry, University of Toronto, Toronto, Canada.; Department of Supportive Care, Princess Margaret Cancer Centre, Toronto, Canada.; Dalla Lana School of Public Health, Joint Centre for Bioethics, University of Toronto, Toronto, Canada.
Jazyk: angličtina
Zdroj: Death studies [Death Stud] 2023; Vol. 47 (3), pp. 296-306. Date of Electronic Publication: 2022 Apr 20.
DOI: 10.1080/07481187.2022.2063456
Abstrakt: In most jurisdictions where medical assistance in dying (MAiD) is legal, patients must have decision-making capacity. Brain cancer often damages the cognitive networks required to maintain decision-making capacity. Using qualitative methodology guided by a relational ethics conceptual framework, this study explored neuro-oncology clinicians' perspectives on access to and eligibility for MAiD for patients diagnosed with brain cancer. We interviewed 24 neuro-oncology clinicians from 6 countries. Participants described the unique challenges facing brain cancer patients, potentially resulting in their inequitable access to MAiD. The findings highlight the importance of early end-of-life conversations, advance care planning, and access to end-of-life treatment options.
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje